Cover Image

Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study

Show other versions (1)

Pancreatic cancer (PaC) remains extremely lethal worldwide even after resection. PaC resection rates are low, making prognostic studies in resected PaC difficult. This large international population-based study aimed at exploring factors associated with survival in patients with resected TNM stage I...

Full description

Saved in:
Bibliographic Details
Main Authors: Huang, Lei (Author) , Balavarca, Yesilda (Author) , Schrotz-King, Petra (Author) , Brenner, Hermann (Author)
Format: Article (Journal)
Language:English
Published: 25 March 2019
In: BMC medicine
Year: 2019, Volume: 17
ISSN:1741-7015
DOI:10.1186/s12916-019-1304-y
Online Access:Verlag, Volltext: https://doi.org/10.1186/s12916-019-1304-y
Get full text
Author Notes:Lei Huang, Yesilda Balavarca, Lydia van der Geest, Valery Lemmens, Liesbet Van Eycken, Harlinde De Schutter, Tom B. Johannesen, Vesna Zadnik, Maja Primic-Žakelj, Margit Mägi, Robert Grützmann, Marc G. Besselink, Petra Schrotz-King, Hermann Brenner and Lina Jansen
Description
Summary:Pancreatic cancer (PaC) remains extremely lethal worldwide even after resection. PaC resection rates are low, making prognostic studies in resected PaC difficult. This large international population-based study aimed at exploring factors associated with survival in patients with resected TNM stage I-II PaC receiving chemotherapy and at developing and internationally validating a survival-predicting model.
Item Description:Gesehen am 08.04.2019
Physical Description:Online Resource
ISSN:1741-7015
DOI:10.1186/s12916-019-1304-y

Similar Items